What Is ‘Ozempic Personality’ and Can GLP-1s Really Reduce Your Ability to Feel Excitement and Joy?

Can GLP-1s Cause Emotional ‘Flattening,’ Nicknamed ‘Ozempic Personality’?

Can GLP-1s Cause Emotional ‘Flattening,’ Nicknamed ‘Ozempic Personality’?
Getty Images

“Ozempic personality” is a new term making the rounds on social media, describing a subtle emotional shift that some people say they’ve noticed as a side effect of GLP-1 weight loss medications.

These GLP-1 users report less excitement and joy, fewer emotional highs and lows, and a general feeling that life is gray, flat, or “meh.”

Ozempic personality does not appear to be a social media myth. “It’s not super common, but common enough to see it in practice, and it’s generally at the higher [GLP-1] doses,” says Spencer Nadolsky, DO, a family physician and obesity medicine and lipid specialist in Holland, Michigan.

“I bring patients down in the dose and it tends to resolve,” he adds, meaning symptoms improve or disappear.

Dopamine May Help Explain Ozempic Personality

Ozempic personality (not a real medical term) appears to be a type of anhedonia, defined as a reduced ability to feel interest or take pleasure in activities that are typically enjoyable.

 Anhedonia can also show up as an overall feeling of disengagement — and it’s a key symptom of many mental health conditions, like depression.

Ozempic personality “is not the same as depression, though it can overlap,” says Uma Naidoo, MD, a nutritional psychiatrist and director of nutritional and lifestyle psychiatry at Massachusetts General Hospital in Boston. “This does not mean the medication is causing depression,” she notes.

A common denominator between depression and Ozempic personality appears to be dopamine, a neurotransmitter (a type of chemical messenger) that plays a role in the brain’s reward system. Low dopamine levels and depression are linked.

GLP-1s, meanwhile, work in part by blunting the impact of dopamine on the brain’s reward pathways, not only reducing cravings for food but also for other stimuli usually connected to feelings of excitement and pleasure.

“From a nutritional psychiatry perspective, this reflects a shift in how the brain processes reward signals — and it explains both the therapeutic effect [of GLP-1s], such as reduced cravings and improved control, and the potential side effect of experiencing a reduced overall drive or pleasure,” says Dr. Naidoo.

GLP-1s Often Improve Mental Health

While concerns about emotional flattening have been garnering attention, available evidence does not suggest that GLP-1 medications increase the risk of depression or cause serious psychiatric side effects.

In fact, emerging research shows these medications may help improve mental health, with one large study finding that GLP-1 users in Sweden with depression and anxiety took fewer mental health sick days and required fewer psychiatric hospitalizations when they were using the medications, compared with when they weren’t.

The ability of these powerful medications to help people who may have previously struggled unsuccessfully to combat obesity — for years or even decades — can boost mental health, experts say. “A lot of these changes with GLP-1s improve mental health because people finally have hope. It can be quite freeing to patients,” says Dr. Nadolsky.

Many people on GLP-1s report positive changes to their mental health due to the quieting of “food noise” — persistent thoughts and mental chatter around eating. “GLP-1 medications reduce food noise by acting on the brain’s reward circuitry,” Naidoo explains.

This mechanism appears to extend to cravings beyond food. “Because the same brain reward system is involved in other behaviors — such as alcohol use, shopping, or social media — some individuals notice changes beyond eating,” Naidoo says.

Weight Loss and Decreased Interest in Food Can Sometimes Cause Their Own Stress

For people with obesity who’ve used food as a way to deal with difficult emotions or mental health challenges, the changes caused by GLP-1s may result in what Naidoo calls “a coping gap.”

“It may reveal underlying emotional needs that were previously buffered by those behaviors — and this creates an important opportunity to develop healthier, more sustainable coping strategies,” she says.

At the same time, the significant physiological changes that happen with GLP-1 medications — most noticeably, a drastic reduction in body weight — could also contribute to emotional flux as the brain adjusts to a new physical appearance and other people’s sometimes complicated reactions.

“Any physical changes that happen too quickly can be stressful for the mind,” says Asim A. Shah, MD, professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine in Houston. “Rapid weight loss can lead to changes in personality or mental well-being — and some people may or may not be able to handle it.”

What to Do if You Think You May Need Help

Subtle emotional shifts while on GLP-1 medications may not be cause for concern, but it’s worth paying attention to psychological changes that interfere with daily life.

“It really comes down to hobbies,” Nadolsky says. “Like when you stop wanting to participate in things you enjoyed before [going on GLP-1s].”

Other signs that Naidoo recommends watching for include:

  • Persistent emotional flatness lasting more than two weeks
  • Withdrawing from friends or routines
  • Low motivation
  • A sense that nothing feels rewarding

If healthy lifestyle factors like maintaining a structured exercise routine, eating a nutritious diet, getting enough sleep, and making time for social activities don’t seem to be effective for your emotional well-being while on a GLP-1 medication, it’s a good idea to check in with a clinician, Dr. Shah says. “If you feel that the severity of your emotional side effects is high and the duration has been persistent — immediately see your provider.”

A healthcare provider can help with weighing the benefits you’re getting from GLP-1 medications against any emotional side effects you may be experiencing — potentially adjusting dosage or medication type and recommending additional mental health support, if needed.

“Dialing in the correct dose is important, but also community with others going through the same journey,” says Nadolsky.

The Takeaway

  • Anecdotal reports of “Ozempic personality” refer to a flattening of motivation, desire, and emotional highs that some patients taking GLP-1 medications may experience.
  • Research suggests that GLP-1 medications don’t just reduce hunger, they alter the brain’s reward system — dampening many types of cravings, food noise, and the urge to seek pleasure.
  • Experts recommend talking to a healthcare provider if emotional shifts seem intense or long-lasting. Adjusting the medication dosage may help.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Anhedonia. Cleveland Clinic. July 26, 2023.
  2. Dopamine Deficiency. Cleveland Clinic. March 23, 2022.
  3. Lewis RG et al. The Brain’s Reward System in Health and Disease. Advances in Experimental Medicine and Biology. April 8, 2022.
  4. Pierret ACS et al. Glucagon-Like Peptide 1 Receptor Agonists and Mental Health: A Systematic Review and Meta-Analysis. JAMA Psychiatry. May 14, 2025.
  5. Taipale H et al. Association Between GLP-1 Receptor Agonist Use and Worsening Mental Illness in People with Depression and Anxiety in Sweden: a National Cohort Study. The Lancet. April 2026.
  6. Eren-Yazicioglu CY et al. Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review Analysis of Studies on Palatable Food, Drugs of Abuse, and Alcohol. Frontiers in Behavioral Neuroscience. January 18, 2021.
  7. Klausen MK et al. The Role of Glucagon-like Peptide (GLP-1) in Addictive Disorders. British Journal of Pharmacology. September 16, 2021.
  8. Pona A. How Significant Weight Loss Can Affect Your Mental Health. Ohio State University. January 24, 2025.
Natalia-Johnsen-bio

Natalia Johnsen, MD

Medical Reviewer

Natalia Johnsen, MD, is a triple board-certified physician in internal medicine, lifestyle medicine, and obesity medicine, practicing as an internist and consultant at the Vancouve...

Cristina Mutchler

Cristina Mutchler

Author

Cristina Mutchler is an award-winning journalist with more than a decade of experience covering health and wellness content for national outlets. She previous worked at CNN, Newsy,...